Opexa (OPXA) initiates discussions with Health Canada in Pre-CTA Meeting
June 2nd, 2011
No comments
Health Canada provides guidance on clinical trial Protocol for planned P3 Clinical Trial Read more…
Categories: NASDAQ:OPXA, Opexa Therapeutics (OPXA), pre-CTA consultation meeting
